Literature DB >> 10704171

Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits.

D D Lund1, F M Faraci, F J Miller, D D Heistad.   

Abstract

BACKGROUND: Diabetes mellitus is associated with impairment of NO-mediated vascular relaxation. The purpose of this study was to determine whether adenovirus-mediated gene transfer of endothelial NO synthase (eNOS) or Cu/Zn superoxide dismutase (SOD1) improves responsiveness to acetylcholine in alloxan-induced diabetic rabbits. METHODS AND
RESULTS: After 8 weeks, plasma glucose was greater in diabetic rabbits (418+/-35 mg/dL) (mean+/-SEM) than in normal rabbits (105+/-4 mg/dL). Carotid arteries were removed and cut into ring segments. Arteries were incubated for 2 hours with adenoviral vectors driven by a CMV promoter expressing beta-galactosidase (beta-gal), eNOS, SOD1, or vehicle. After incubation with virus, arteries were incubated for an additional 24 hours to allow transgene expression. Vascular reactivity was examined by recording isometric tension. After precontraction with phenylephrine, responses to the endothelium-independent vasodilator sodium nitroprusside were similar in diabetic and normal arteries. Endothelium-dependent relaxation to acetylcholine (3x10(-6) mol/L) was significantly less in arteries from diabetic animals (68+/-5%) than in normal vessels (90+/-3%). Adenoviral transfection of arteries with eNOS improved relaxation in response to acetylcholine in diabetic (EC(50) eNOS=0.64+/-0.12x10(-7) mol/L versus vehicle =1. 70+/-0.43x10(-7) mol/L) but not normal arteries. Vasorelaxation in response to acetylcholine was inhibited by N(omega)-nitro-L-arginine (100 micromol/L) in all groups. Responses to acetylcholine were unchanged after gene transfection of SOD1 or beta-gal in arteries from diabetic or normal rabbits.
CONCLUSIONS: Adenovirus-mediated gene transfer of eNOS, but not SOD, improves impaired NO-mediated relaxation in vessels from diabetic rabbits.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704171     DOI: 10.1161/01.cir.101.9.1027

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

Review 1.  The future of gene therapy for stroke.

Authors:  C A Gunnett; D D Heistad
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

2.  Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension.

Authors:  Giuseppe Faraco; Yukio Sugiyama; Diane Lane; Lidia Garcia-Bonilla; Haejoo Chang; Monica M Santisteban; Gianfranco Racchumi; Michelle Murphy; Nico Van Rooijen; Joseph Anrather; Costantino Iadecola
Journal:  J Clin Invest       Date:  2016-11-14       Impact factor: 14.808

Review 3.  Hypertension, stroke, and endothelium.

Authors:  Francesco Cosentino; Massimo Volpe
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

4.  Thioredoxin reduces post-ischemic myocardial apoptosis by reducing oxidative/nitrative stress.

Authors:  L Tao; E Gao; A Hu; C Coletti; Y Wang; T A Christopher; B L Lopez; W Koch; X L Ma
Journal:  Br J Pharmacol       Date:  2006-08-21       Impact factor: 8.739

5.  Essential role of caveolin-3 in adiponectin signalsome formation and adiponectin cardioprotection.

Authors:  Yajing Wang; Xiaoliang Wang; Jean-François Jasmin; Wayne Bond Lau; Rong Li; Yuexin Yuan; Wei Yi; Kurt Chuprun; Michael P Lisanti; Walter J Koch; Erhe Gao; Xin-Liang Ma
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-09       Impact factor: 8.311

6.  L-Arginine prevents metabolic effects of high glucose in diabetic mice.

Authors:  Matthew B West; Kota V Ramana; Karin Kaiserova; Satish K Srivastava; Aruni Bhatnagar
Journal:  FEBS Lett       Date:  2008-06-27       Impact factor: 4.124

7.  A pivotal role of endothelial-specific NF-kappaB signaling in the pathogenesis of septic shock and septic vascular dysfunction.

Authors:  Jianqiang Ding; Dongmei Song; Xiaobing Ye; Shu Fang Liu
Journal:  J Immunol       Date:  2009-08-19       Impact factor: 5.422

Review 8.  Gene therapy for cerebral vascular disease: update 2003.

Authors:  Kazunori Toyoda; Yi Chu; Donald D Heistad
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

9.  INO-4885 [5,10,15,20-tetra[N-(benzyl-4'-carboxylate)-2-pyridinium]-21H,23H-porphine iron(III) chloride], a peroxynitrite decomposition catalyst, protects the heart against reperfusion injury in mice.

Authors:  Xiang-Ying Jiao; Erhe Gao; Yuexin Yuan; Yajing Wang; Wayne Bond Lau; Walter Koch; Xin-Liang Ma; Ling Tao
Journal:  J Pharmacol Exp Ther       Date:  2008-11-25       Impact factor: 4.030

10.  Endothelial dysfunction in adiponectin deficiency and its mechanisms involved.

Authors:  Yu Cao; Ling Tao; Yuexing Yuan; Xiangying Jiao; Wayne Bond Lau; Yajing Wang; Theodore Christopher; Bernard Lopez; Lawrence Chan; Barry Goldstein; Xin L Ma
Journal:  J Mol Cell Cardiol       Date:  2008-11-05       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.